相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mo1116 The Efficacy and Safety of Rifaximin vs. Vancomycin in the Treatment of Mild to Moderate C. difficile Infection: A Randomized Double-Blind Active Comparator Trial
Darrell S. Pardi et al.
GASTROENTEROLOGY (2015)
Appendectomy Is Not Associated With Adverse Outcomes in Clostridium difficile Infection: A Population-Based Study
Sahil Khanna et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
American Journal of Gastroenterology Lecture: Intestinal Microbiota and the Role of Fecal Microbiota Transplant (FMT) in Treatment of C. difficile Infection
Lawrence J. Brandt
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections
Christina M. Surawicz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Fidaxomicin Chaser Regimen Following Vancomycin for Patients With Multiple Clostridium difficile Recurrences
Stuart Johnson et al.
CLINICAL INFECTIOUS DISEASES (2013)
Markers of Intestinal Inflammation, Not Bacterial Burden, Correlate With Clinical Outcomes in Clostridium difficile Infection
Rana E. El Feghaly et al.
CLINICAL INFECTIOUS DISEASES (2013)
Is Fidaxomicin Worth the Cost? An Economic Analysis
Sarah M. Bartsch et al.
CLINICAL INFECTIOUS DISEASES (2013)
The Epidemiology of Clostridium difficile Infection in Children: A Population-Based Study
Sahil Khanna et al.
CLINICAL INFECTIOUS DISEASES (2013)
An overview of fecal microbiota transplantation: techniques, indications, and outcomes
Lawrence J. Brandt et al.
GASTROINTESTINAL ENDOSCOPY (2013)
Acute Kidney Injury is an Independent Marker of Severity in Clostridium difficile Infection: A Nationwide Survey
Sahil Khanna et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Fecal Microbiota Transplantation - An Old Therapy Comes of Age
Ciaran P. Kelly
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
Els van Nood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cost-Effectiveness Analysis Evaluating Fidaxomicin versus Oral Vancomycin for the Treatment of Clostridium difficile Infection in the United States
Paul M. Stranges et al.
VALUE IN HEALTH (2013)
Epidemiology of Community-Associated Clostridium difficile Infection, 2009 Through 2011
Amit S. Chitnis et al.
JAMA INTERNAL MEDICINE (2013)
Outcomes in community-acquired Clostridium difficile infection
S. Khanna et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study
Sahil Khanna et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent Clostridium difficile Infection
Matthew J. Hamilton et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection
Lawrence J. Brandt et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Probiotics for the Prevention of Clostridium difficile-Associated Diarrhea A Systematic Review and Meta-analysis
Bradley C. Johnston et al.
ANNALS OF INTERNAL MEDICINE (2012)
Evaluation of an Oral Suspension of VP20621, Spores of Nontoxigenic Clostridium difficile Strain M3, in Healthy Subjects
Stephen A. Villano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Gastric Acid Suppression and Clostridium difficile Infection: Is There a Causal Connection?
Sahil Khanna et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Fidaxomicin Failures in Recurrent Clostridium difficile Infection: A Problem of Timing
Robert Orenstein
CLINICAL INFECTIOUS DISEASES (2012)
Community-Acquired Clostridium difficile Infection: An Emerging Entity
Sahil Khanna et al.
CLINICAL INFECTIOUS DISEASES (2012)
Fidaxomicin: The Newest Addition to the Armamentarium Against Clostridium difficile Infections
Jason W. Lancaster et al.
CLINICAL THERAPEUTICS (2012)
Clostridium Difficile of the Ileum Following Total Abdominal Colectomy, With or Without Proctectomy: Who Is at Risk?
Athanasios Tsiouris et al.
DISEASES OF THE COLON & RECTUM (2012)
Fecal Transplantation, Through Colonoscopy, Is Effective Therapy for Recurrent Clostridium difficile Infection
Eero Mattila et al.
GASTROENTEROLOGY (2012)
An Evaluation of Repeat Stool Testing for Clostridium difficile Infection by Polymerase Chain Reaction
Sahil Khanna et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2012)
IBD Poor outcomes after Clostridium difficile infection in IBD
Sahil Khanna et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Gastric Acid Suppression and Outcomes in Clostridium difficile Infection: A Population-Based Study
Sahil Khanna et al.
MAYO CLINIC PROCEEDINGS (2012)
Clostridium difficile Infection in Patients With Chronic Kidney Disease
Mira T. Keddis et al.
MAYO CLINIC PROCEEDINGS (2012)
Clostridium difficile Infection: New Insights Into Management
Sahil Khanna et al.
MAYO CLINIC PROCEEDINGS (2012)
Tests for the diagnosis of Clostridium difficile infection: The next generation
Karen C. Carroll
ANAEROBE (2011)
Diverting Loop Ileostomy and Colonic Lavage An Alternative to Total Abdominal Colectomy for the Treatment of Severe, Complicated Clostridium difficile Associated Disease
Matthew D. Neal et al.
ANNALS OF SURGERY (2011)
Incidence of and risk factors for community-associated Clostridium difficile infection: A nested case-control study
Jennifer L. Kuntz et al.
BMC INFECTIOUS DISEASES (2011)
The Appendix May Protect Against Clostridium difficile Recurrence
Gene Y. Im et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Treating Clostridium difficile Infection With Fecal Microbiota Transplantation
Johan S. Bakken et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections
Kathleen M. Mullane et al.
CLINICAL INFECTIOUS DISEASES (2011)
Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection
Ethan Gough et al.
CLINICAL INFECTIOUS DISEASES (2011)
Intravenous Immunoglobulin for the Treatment of Clostridium difficile Infection: A Review
Marwan S. Abougergi et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Community-Acquired Clostridium difficile-Associated Diarrhea, Montreal, 2005-2006: Frequency Estimates and Their Validity
Robert Allard et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)
Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals
Becky A. Miller et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)
Comparison of Clinical Severity Score Indices for Clostridium difficile Infection
Shigeki Fujitani et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)
A Targeted Strategy to Wipe Out Clostridium difficile
Robert Orenstein et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)
A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection
Kevin W. Garey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
CSI: a severity index for Clostridium difficile infection at the time of admission
O. A. Lungulescu et al.
JOURNAL OF HOSPITAL INFECTION (2011)
Fidaxomicin forClostridium difficileInfection
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Thomas J. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rifaximin Is Effective for the Treatment of Clostridium difficile-Associated Diarrhea: Results of an Open-Label Pilot Study
David T. Rubin et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2011)
Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection
Amy Linsky et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases
Hoonmo L. Koo et al.
CURRENT OPINION IN GASTROENTEROLOGY (2010)
Disease transmission model for community-associated Clostridium difficile infection
A. M. Otten et al.
EPIDEMIOLOGY AND INFECTION (2010)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Intravenous immunoglobulin for the treatment of severeClostridium difficilecolitis: An observational study and review of the literature
Marwan S. Abougergi et al.
Journal of Hospital Medicine (2010)
Detection and characterization of Clostridium difficile in retail chicken
J. S. Weese et al.
LETTERS IN APPLIED MICROBIOLOGY (2010)
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Israel Lowy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)
Brett A. Leav et al.
VACCINE (2010)
Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea
Ji Won Kim et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients
Lynne V. McFarland
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings
Sahil Khanna et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Nitazoxanide versus Vancomycin in Clostridium difficile Infection: A Randomized, Double-Blind Study
Daniel M. Musher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile Infection
Mary Y. Hu et al.
GASTROENTEROLOGY (2009)
Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes
Stuart Johnson
JOURNAL OF INFECTION (2009)
In Vitro Activity of OPT-80 Tested against Clinical Isolates of Toxin-Producing Clostridium difficile
James A. Karlowsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
OPT-80, a macrocyclic antimicrobial agent for the treatment of Clostridium difficile infections:: a review
Michael Gerber et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals
Erik R. Dubberke et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection
Lynne M. Sloan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
K. W. Garey et al.
JOURNAL OF HOSPITAL INFECTION (2008)
Clostridium difficile— More Difficult Than Ever
Ciarán P. Kelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
INCREASE IN CLOSTRIDIUM DIFFICILE-RELATED HOSPITALIZATIONS AMONG INFANTS IN THE UNITED STATES, 2000-2005
Marya D. Zilberberg et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Epidemiological Features of Clostridium difficile-Associated Disease Among Inpatients at Children's Hospitals in the United States, 2001-2006
Jason Kim et al.
PEDIATRICS (2008)
Toxinotype V Clostridium difficile in humans and food animals
Michael A. Jhung et al.
EMERGING INFECTIOUS DISEASES (2008)
Probiotics for treatment of Clostridium difficile-associated colitis in adults
A. Pillai et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Increase in adult Clostrillium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005
Marya D. Zilberberg et al.
EMERGING INFECTIOUS DISEASES (2008)
Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system
Jaime Belmares et al.
JOURNAL OF INFECTION (2007)
Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis
Richard M. Cadle et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
Efficacy of rifaximin and vancomycin combination therapy in a patient with refractory Clostridium difficile-associated diarrhea
Arthur L. Berman
JOURNAL OF CLINICAL GASTROENTEROLOGY (2007)
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -: Associated diarrhea, stratified by disease severity
Fred A. Zar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States
Rocco Ricciardi et al.
ARCHIVES OF SURGERY (2007)
Nitazoxanide versus metronidazole for Clostridium difficile-associated colitis - Reply to Young et al.
Daniel M. Musher et al.
CLINICAL INFECTIOUS DISEASES (2007)
In vitro killing of nosocomial pathogens by acid and acidified nitrite
Agam Rao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy
Sandra Dial et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease
S Dial et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea:: A cohort study during an epidemic in Quebec
J Pépin et al.
CLINICAL INFECTIOUS DISEASES (2005)
Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada
J Pépin et al.
CLINICAL INFECTIOUS DISEASES (2005)
Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole
DM Musher et al.
CLINICAL INFECTIOUS DISEASES (2005)
A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea
HL DuPont et al.
ANNALS OF INTERNAL MEDICINE (2005)
A large outbreak of Clostridium Difficile -: Associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use
CA Muto et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2005)
Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003:: a changing pattern of disease severity
J Pépin et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2004)
In vitro activities of OPT-80 and comparator drugs against intestinal bacteria
SA Finegold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vitro activity of OPT-80 against clostridium difcile
G Ackermann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Lactobacillus plantarum 299v for the treatment of recurrent clostridium difficile-associated diarrhoea:: A double-blind, placebo-controlled trial
M Wullt et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2003)
Breaking the cycle:: Treatment strategies for 163 cases of recurrent Clostridium difficile disease
LV McFarland et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2002)
The search for a better treatment for recurrent Clostridium difficile disease:: Use of high-dose vancomycin combined with Saccharomyces boulardii
CM Surawicz et al.
CLINICAL INFECTIOUS DISEASES (2000)
分享论文
